Gossamer Bio, Inc.
GOSS
$1.45
$0.1511.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 61.77% | 60.90% | 21.82% | 21.61% | 18.47% |
| Total Depreciation and Amortization | -9.33% | -9.99% | -5.39% | -0.99% | -1.87% |
| Total Amortization of Deferred Charges | -9.90% | -1.35% | 3.19% | 13.59% | -51.42% |
| Total Other Non-Cash Items | -31.22% | -35.38% | -28.43% | -27.71% | -28.44% |
| Change in Net Operating Assets | 335.99% | 701.14% | -115.97% | -232.83% | -563.59% |
| Cash from Operations | 99.19% | 97.80% | 15.05% | 14.90% | 3.53% |
| Capital Expenditure | -- | -- | -- | -- | 73.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.20% | -1,798.67% | -11,987.29% | -17,655.20% | -6,694.61% |
| Cash from Investing | 56.25% | -1,828.69% | -7,815.28% | -10,621.74% | -9,436.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | -58.33% | -33.34% | -100.02% | -300.03% |
| Issuance of Common Stock | -99.69% | 64.66% | 64.64% | 64.18% | 63.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -107.57% | 65.75% | 67.03% | 62.40% | 58.05% |
| Foreign Exchange rate Adjustments | -60.87% | -105.83% | 91.75% | 121.28% | 136.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.60% | 187.02% | 64.22% | -11.71% | -17.99% |
